Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

DSpace Repository

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

Author: Harder, J.; Ihorst, G.; Heinemann, V.; Hofheinz, R.; Moehler, M.; Buechler, P.; Kloeppel, G.; Roecken, C.; Bitzer, M.; Boeck, S.; Endlicher, E.; Reinacher-Schick, A.; Schmoor, C.; Geissler, M.
Tübinger Autor(en):
Bitzer, Michael
Published in: British Journal of Cancer (2012), Bd. 106, H. 6, S. 1033-1038
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/bjc.2012.18
ISSN: 0007-0920
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)